Société Tunisienne des Maladies Respiratoires et d'Allergologie STMRA - COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”.

COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”.

Zouhair Souissi

11 novembre 2021

COVID antiviral pills: what scientists still want to know – Nature Related: [Press release – not published yet] RCT: Pfizer’s novel Covid-19 oral antiviral treatment candidate reduced risk of hospitalization or death by 89% in interim analysis of phase 2/3 EPIC-HR study. A prominent virologist warns new COVID-19 pill could unleash dangerous mutants. Others see […]

The post COVID antiviral pills: what scientists still want to know – “Drugs like Molnupiravir and Paxlovid could change the course of the pandemic if clinical trial results hold up in the real world”. appeared first on Links Medicus.

Lu 573 fois